1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPage title confirms the 2026 AI Accelerator Grant from the Global Ovarian Cancer Research Consortium, but detailed application content was not fully rendered
AI Accelerator Grant is sponsored by Global Ovarian Cancer Research Consortium (Ovarian Cancer Research Alliance (OCRA, USA), Ovarian Cancer Action (OCA, UK), Ovarian Cancer Canada (OCC), and The Ovarian Cancer Research Foundation (OCRF, Australia)). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Ovarian Cancer AI Accelerator Grant 2026 | OCRA Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery On World Ovarian Cancer Day, May 8, the Global Ovarian Cancer Research Consortium announces a second $1 million USD grant along with AWS compute support to power research that aims to improve ovarian cancer survival rates On World Ovarian Cancer Day the Global Ovarian Cancer Research Consortium , of which Ovarian Cancer Research Alliance (OCRA) is a founding partner, today announced the launch of its second $1 million USD AI Accelerator Grant , a major research initiative designed to harness artificial intelligence and large-scale data to accelerate progress against ovarian cancer while promoting international collaboration.
The Consortium’s AI Accelerator Grants are designed to support innovative, data-intensive research projects that leverage cutting-edge computational approaches to address some of the most pressing challenges in ovarian cancer, including prevention, initiation, and early detection; the tumor ecosystem; and treatment resistance.
The initiative builds on the Consortium’s mission to unite global expertise and resources to drive faster, more meaningful breakthroughs and advance research that improves survival and outcomes for patients worldwide. AI is already revolutionizing cancer diagnoses—from breast to brain, skin to thyroid—with stunning advances.
But ovarian cancer has yet to realize the full power of this transformation–funding has lagged behind other diseases despite the high mortality rate and rising number of diagnoses. The Consortium is committed to changing this, launching their first $1 million initiative last year .
Twenty-one international teams, each comprised of researchers from Australia, Canada, the United Kingdom and the United States competed, with the first grant announced earlier this year. This is about fundamentally changing the pace and possibility of ovarian cancer research,” said Audra Moran, President and CEO of Ovarian Cancer Research Alliance (OCRA) .
“By combining global collaboration, advanced AI, and the power of shared data, we are creating an environment where discoveries can happen faster—and where each insight has the potential to benefit patients everywhere. On World Ovarian Cancer Day, along with our global partners, we are proud to take another step toward a future where better outcomes are not the exception, but the expectation.
As part of the grant, selected researchers will receive in-kind cloud compute credits from Amazon Web Services (AWS) to use within Ovarian Cancer Research Alliance’s AI-enabled, international, collaborative research platform.
By anchoring the work within this shared ecosystem, the Consortium ensures that research funded by the AI Accelerator Grant is conducted in a scalable setting that enables real-time data analysis, cross-institutional collaboration, and the integration of diverse datasets. The Consortium is helping to transform how research is conducted, shifting from isolated efforts to a connected, global model of discovery.
The Global Ovarian Cancer Research Consortium includes Ovarian Cancer Research Alliance (United States), Ovarian Cancer Action (United Kingdom), Ovarian Cancer Canada (Canada), and The Ovarian Cancer Research Foundation (Australia).
Recognizing the need for innovation and worldwide collaboration, the Consortium was created to accelerate progress by uniting stakeholders in collective action to advance collaboration, innovation, and investment in transformative research, promote data sharing, and address unmet needs and access gaps. Letters of Intent for the AI Accelerator Grant open on May 8.
September is Gynecologic and Ovarian Cancer Awareness Month About Gynecologic and Ovarian Cancer Awareness Month September is recognized nationwide as Gynecologic and Ovarian Cancer Awareness Month, a dedicated time to raise awareness for all gynecologic cancers. Throughout the month, OCRA joins forces with patients, caregivers, and supporters to amplify our voices.
We focus on educating the public about risks and symptoms, highlighting the … Continued SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community.
The … Continued Navigating Platinum-Resistant Ovarian Cancer: Everyday Health Shares Coping Strategies and OCRA Resources In an article published by Everyday Health, “Coping With the Emotional Challenges of Platinum-Resistant Ovarian Cancer” (June 10, 2026), Ovarian Cancer Research Alliance (OCRA) community member Amanda Widro shares her experience navigating a platinum-resistant ovarian cancer diagnosis.
Ovarian cancer is considered platinum-resistant when it recurs within six months of finishing platinum-based chemotherapy. Widro, who was … Continued c. startsWith(this.
consentName + '=')); this. isVisible = ! this.
hasConsent(); // 1 year expiry; SameSite=Lax + Secure for sane defaults. const oneYear = 60 * 60 * 24 * 365; x-transition. opacity.
duration. 300ms class="pointer-events-none fixed bottom-0 left-0 px-6 pb-6"
According to the current listing, eligibility includes: Lead investigators from the US, UK, Canada, and Australia with significant AI integration; awards made to the institution of the Principal Investigator. Confirm the full requirements in the official notice before applying.
The current listing shows $1,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
AI Accelerator Grant is funded by Global Ovarian Cancer Research Consortium (Ovarian Cancer Research Alliance (OCRA, USA), Ovarian Cancer Action (OCA, UK), Ovarian Cancer Canada (OCC), and The Ovarian Cancer Research Foundation (OCRF, Australia)). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDC-RFA-EH-27-0074 posted as a forecast September 22, 2026: 6 expected awards at $750,000 to $900,000. That is flat funding against the expiring cycle — and the only proven way in is the consortium model Arizona used to bring three states under one award.
Read articleRWJF's Health Equity Research for Action puts up ~20 grants of up to $500,000 — but demands a two-year community partnership and a community co-PI. Here's the strategy, set against the brightest foundation-giving outlook since 2022.
Read articleDOE's FY2026 University Nuclear Research Infrastructure Revitalization NOFO closed May 13 with a single multi-year consortium award above $6M. The structure signals where federal nuclear R&D is heading and how universities should organize for FY27.
Read article